U
US BioTec Inc
OTC:USBC
US BioTec Inc
OTC:USBC
Price:
0.48
USD
-5.01%
Market Cap:
$184.4m
US BioTec Inc
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
US BioTec Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
U
|
US BioTec Inc
OTC:USBC
|
Research & Development
-7.4m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$8.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$5.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$6.8B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-5%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-16%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Research & Development
-$5.9B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-14%
|
|
No Stocks Found
US BioTec Inc
Glance View
The company is headquartered in Gleason, Tennessee. The company went IPO on 2004-04-07.
USBC
Intrinsic Value
Not Available
U
See Also
What is US BioTec Inc's Research & Development?
Research & Development
-7.4m
-7.4m
Based on the financial report for Sep 30, 2023, US BioTec Inc's Research & Development amounts to -7.4m .
What is US BioTec Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-54%
-54%
Over the last year, the Research & Development growth was -46%. The average annual Research & Development growth rates for US BioTec Inc have been -54% over the past three years .
